Association and its population heterogeneities between low-density lipoprotein cholesterol and all-cause and cardiovascular mortality: A population-based cohort study

被引:0
|
作者
Lu Jiapeng [1 ]
Zhang Haibo [1 ]
Chen Bowang [1 ]
Yang Yang [1 ]
Cui Jianlan [1 ]
Xu Wei [1 ]
Song Lijuan [1 ]
Yang Hao [1 ]
He Wenyan [1 ]
Zhang Yan [1 ]
Peng Wenyao [1 ]
Li Xi [1 ,2 ,3 ]
机构
[1] National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
[2] Shenzhen Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital Chinese Academy of Medical Sciences, Shenzhen, Guangdong, China
[3] Central China Sub-center of the National Center for Cardiovascular Diseases, Zhengzhou, Henan,
关键词
Low-density lipoprotein cholesterol; Mortality; Association study; Population heterogeneity; Prospective cohort study;
D O I
暂无
中图分类号
R54 [心脏、血管(循环系)疾病];
学科分类号
摘要
Background: The association and its population heterogeneities between low-density lipoprotein cholesterol (LDL-C) and all-cause and cardiovascular mortality remain unknown. We aimed to examine the dose-dependent associations of LDL-C levels with specific types of cardiovascular disease (CVD) mortality and heterogeneities in the associations among different population subgroups.Methods: A total of 2,968,462 participants aged 35-75 years from China Health Evaluation And risk Reduction through nationwide Teamwork (ChinaHEART) (2014-2019) were included. Cox proportional hazard models and Fine-Gray subdistribution hazard models were used to estimate associations between LDL-C categories (<70.0, 70.0-99.9, 100.0-129.9 [reference group], 130.0-159.9, 160.0-189.9, and ≥190.0 mg/dL) and all-cause and cause-specific mortality.Results: During a median follow-up of 3.7 years, 57,391 and 23,241 deaths from all-cause and overall CVD were documented. We observed J-shaped associations between LDL-C and death from all-cause, overall CVD, coronary heart disease (CHD), and ischemic stroke, and an L-shaped association between LDL-C and hemorrhagic stroke (HS) mortality (P for non-linearity <0.001). Compared with the reference group (100.0-129.9 mg/dL), very low LDL-C levels (<70.0 mg/dL) were significantly associated with increased risk of overall CVD (hazard ratio [HR]: 1.10, 95% confidence interval [CI]: 1.06-1.14) and HS mortality (HR: 1.37, 95% CI: 1.29-1.45). Very high LDL-C levels (≥190.0 mg/dL) were associated with increased risk of overall CVD (HR: 1.51, 95% CI: 1.40-1.62) and CHD mortality (HR: 2.08, 95% CI: 1.92-2.24). The stronger associations of very low LDL-C with risk of CVD mortality were observed in individuals with older age, low or normal body mass index, low or moderate 10-year atherosclerotic CVD risk, and those without diagnosed CVD or taking statins. Stronger associations between very high LDL-C levels and all-cause and CVD mortality were observed in younger people.Conclusions: People with very low LDL-C had a higher risk of all-cause, CVD, and HS mortality; those with very high LDL-C had a higher risk of all-cause, CVD, and CHD mortality. On the basis of our findings, comprehensive health assessment is needed to evaluate cardiovascular risk and implement appropriate lipid-lowering therapy for people with very low LDL-C.
引用
收藏
相关论文
共 50 条
  • [21] Effects of low-density lipoprotein cholesterol on cardiovascular disease and all-cause mortality in elderly patients (≥75 years old)
    Yu, Jiaxin
    Liu, Xiaokun
    Chen, Shuohua
    Liu, Yan
    Liu, HongMin
    Zheng, Hongwei
    Yang, Ning
    Wu, Shouling
    Li, Yuming
    ENDOCRINE, 2022, 75 (02) : 418 - 426
  • [22] Reduced Kidney Function, Albuminuria, and Risks for All-cause and Cardiovascular Mortality in China: A Population-based Cohort Study
    Wang, Jinwei
    Wang, Fang
    Liu, Shiwei
    Zhou, Maigeng
    Zhang, Luxia
    Zhao, Minghui
    BMC NEPHROLOGY, 2017, 18
  • [23] Reduced Kidney Function, Albuminuria, and Risks for All-cause and Cardiovascular Mortality in China: A Population-based Cohort Study
    Jinwei Wang
    Fang Wang
    Shiwei Liu
    Maigeng Zhou
    Luxia Zhang
    Minghui Zhao
    BMC Nephrology, 18
  • [24] The impact of chronic diseases on all-cause mortality in Spain: A population-based cohort study
    Caride-Miana, Elena
    Orozco-Beltran, Domingo
    Quesada-Rico, Jose Antonio
    Mira-Solves, Jose Joaquin
    ATENCION PRIMARIA, 2025, 57 (05):
  • [25] The association between Naples Prognostic Score and all-cause and cardiovascular mortality in the general population with metabolic syndrome: A cohort study
    Chen, Zhongying
    Chen, Zhe
    Zhong, Yuqi
    Wang, Qizeng
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2025, 35 (01)
  • [26] Associations of stroke with all-cause and cause-specific mortality: A population-based matched cohort study
    Kim, Juyeong
    Park, Eun-Cheol
    JOURNAL OF PUBLIC HEALTH, 2023, 45 (01) : 66 - 74
  • [27] All-cause and cause-specific mortality by spirometric pattern and sex - a population-based cohort study
    Backman, Helena
    Sawalha, Sami
    Nilsson, Ulf
    Hedman, Linnea
    Stridsman, Caroline
    Vanfleteren, Lowie E. G. W.
    Nwaru, Bright I.
    Stenfors, Nikolai
    Ronmark, Eva
    Lindberg, Anne
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2024, 18
  • [28] Bone mineral density and osteoporosis in relation to all-cause and cause-specific mortality in NHANES: A population-based cohort study
    Cai, Shaofang
    Fan, Jiayao
    Zhu, Lina
    Ye, Jianhong
    Rao, Xianming
    Fan, Chunhong
    Zhong, Yaohong
    Li, Yingjun
    BONE, 2020, 141
  • [29] Evaluation of the Association between Low-Density Lipoprotein (LDL) and All-Cause Mortality in Geriatric Patients with Hip Fractures: A Prospective Cohort Study of 339 Patients
    Kang, Xin
    Tian, Bin
    Zhao, Zan-Dong
    Zhang, Bin-Fei
    Zhang, Ming
    JOURNAL OF PERSONALIZED MEDICINE, 2023, 13 (02):
  • [30] Extent of Low-density Lipoprotein Cholesterol Reduction and All-cause and Cardiovascular Mortality Benefit: A Systematic Review and Meta-analysis
    Ennezat, Pierre Vladimir
    Guerbaai, Raphaelle-Ashley
    Marechaux, Sylvestre
    Le Jemtel, Thierry H.
    Francois, Patrice
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2023, 81 (01) : 35 - 44